Company Filing History:

7 out of 266

Pierre Fabre Medicament

Years Active: 1984-2001

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6303603 - 3-oxo-2(H)-1,2,4-triazine derivatives as ligands of 5 HT1A receptors (2001-10-16),

2. 5760087 - Glycylanilide derivatives, their preparation and their application in (1998-06-02),

3. 5633255 - 1,2-dihydro-2-oxo-3-aminoquinoxaline derivatives, their preparation and (1997-05-27),

4. 5591743 - 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives as 5HT.sub.1A ligands (1997-01-07),

5. 5254554 - 3-hydroxy-substituted-1-phenyl-1,4-dihydro-4-oxopyridazines and (1993-10-19),

6. 5182273 - Spirocyclic N, O derivatives of cyclotriphosphazenes and their use in (1993-01-26),

7. 5059599 - Derivatives of 1-phenyl 1,4-dihydro 3-amino 4-oxo pyridazines, their (1991-10-22),

8. 4714789 - Halo-biphenyl tertiary alcohols useful in therapy in the treatment of (1987-12-22),

9. 4436749 - Compounds of the benzoxepine series and sulphur- and nitrogen-containing (1984-03-13),

Title: Innovations of Jean-Francois Patoiseau

Introduction

Jean-Francois Patoiseau is a notable inventor based in Castres, France. He has made significant contributions to the field of medicinal chemistry, holding a total of nine patents. His work primarily focuses on the development of novel compounds with potential therapeutic applications.

Latest Patents

One of his latest patents includes the invention of 3-oxo-2(H)-1,2,4-triazine derivatives as ligands of 5 HT1A receptors. This invention concerns novel 3-oxo-(2H)-1,2,4-triazine derivatives of a specific general formula. The compounds feature various substituents, including hydrogen, linear or branched alkyl groups, and phenyl alkyl groups, which may be further substituted by groups such as alkyl, alkoxy, halogen, or trifluoromethyl. These derivatives are designed to interact with 5 HT1A receptors, which are important in various biological processes.

Career Highlights

Throughout his career, Jean-Francois Patoiseau has worked with prominent companies in the pharmaceutical industry, including Pierre Fabre Medicament and Pierre Fabre S.A. His expertise in medicinal chemistry has allowed him to contribute to the development of innovative therapeutic agents.

Collaborations

He has collaborated with notable colleagues such as Jean-Marie Autin and Dennis C. Bigg. These partnerships have facilitated the advancement of his research and the successful development of his patented inventions.

Conclusion

Jean-Francois Patoiseau's contributions to medicinal chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His innovative work continues to pave the way for new therapeutic possibilities.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.